Nasal Cannula Market, By Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula), By Material (Plastic, Silicon ), By Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD, , Cystic fibrosis, Pneumonia and Others ), By End User (Hospital, Long term care center, Home care settings, Ambulatory surgical centers, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023

Code : CMI2694

Pages :210

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Nasal Cannula Market: Key Developments

In June 2022, McArthur Medical Sales, a manufacturing and distributing company, announced a distribution agreement with Breas Medical, a medical device company, to distribute the Breas Medical Vivo 1-2-3 family of bilevel devices and accessories in Canada. The Vivo 1-2-3 product family is a bilevel ventilator offering both ‘noninvasive’ and invasive (Vivo 3 only) ventilation for non-dependent patients with chronic breathing insufficiency. The devices feature a built-in humidifier with a heated wire circuit, a comprehensive set of modes with auto-EPAP and high-flow nasal cannula therapy, and SpO2 monitoring.
In August 2021, ResMed, a medical device company, launched AirSense 11 in the U.S., the company’s next-generation PAP (positive airway pressure) device designed for therapy to treat and manage sleep apnea.
In April 2021, Vapotherm, a medical technology company focused on the development and commercialization of its proprietary Hi-VNI Technology products that are used to treat patients suffering from respiratory distress, announced a major expansion in its capital equipment manufacturing capabilities. The Precision Flow Hi-VNI system is an advanced high-flow nasal cannula (HFNC) system using high velocity to treat the respiratory distress experienced by COVID-19 patients.

Global Nasal Cannula Market: Key Trends

Increasing government initiatives: Increasing government initiatives by government organizations are expected to drive market growth over the forecast period. For instance, in June 2021, the Pan American Health Organization/World Health Organization (PAHO/WHO) and the Government of Canada donated six (6) high-flow nasal cannula (HFNC) systems and two (2) advanced patient monitors with carbon dioxide (CO2) and invasive blood pressure (IBP) monitoring, including accessories and consumables, to the Karl Heusner Memorial Hospital (KHMH). High-Flow Nasal Cannula (HFNC) Treatment is a non-invasive respiratory support therapy that delivers warm, humidified, oxygen-enriched air to patients, usually using a nasal tube called a cannula.